glp 1 and stroke GLP-1 Receptor Agonists as Treatment of Nondiabetic Ischemic Stroke: A Systematic Review Meta-Analysis The Paper of The Month
Description
The ADA now recommends GLP1 RAs with proven benefit to slow CKD progression and reduce CV risk in people with type 2 diabetes
This hypothesis is further supported by a study [54] which demonstrated that electrical stimulation of afferent renal nerves activates rostral ventrolateral medulla-projecting paraventricular nucleus (PVN) neurons in the hypothalamus
Medicare GLP-1 Bridge Program: Eligibility Explained Wondering if you qualify for the Medicare GLP-1 Bridge Program
The exact dose depends on your weight, comorbidities, kidney function, and disease activity, and should always be determined by your prescribing physician
Chen S, Liu AR, An FM, Yao WB, Gao XD
